FDA Authorizes Multiple New Medical Therapies

The U.S. Food and Drug Administration has recently approved several new treatments, including advanced therapies for metastatic breast cancer. Additionally, the agency authorized the first generic version of a tuberculosis medication and an over-the-counter naloxone nasal spray to combat opioid overdoses. These approvals aim to broaden treatment options and improve public health access.